Giant cell tumours of the small bones of the hands and feet LONG-TERM RESULTS OF 30 PATIENTS AND A SYSTEMATIC LITERATURE REVIEW

被引:24
|
作者
Oliveira, V. C. [1 ]
van der Heijden, L. [2 ]
van der Geest, I. C. M. [1 ]
Campanacci, D. A. [1 ]
Gibbons, C. L. M. H. [1 ]
de Sande, M. A. J. van [2 ]
Dijkstra, P. D. S. [2 ]
机构
[1] Leiden Univ Med Ctr, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ Med Ctr, Dept Orthopaed Surg, NL-2300 RC Leiden, Netherlands
关键词
CRYOSURGERY; CEMENTATION; RECURRENCE; METACARPAL; CURETTAGE; ADJUVANTS; RISK;
D O I
10.1302/0301-620X.95B6.30876
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Giant cell tumours (GCTs) of the small bones of the hands and feet are rare. Small case series have been published but there is no consensus about ideal treatment. We performed a systematic review, initially screening 775 titles, and included 12 papers comprising 91 patients with GCT of the small bones of the hands and feet. The rate of recurrence across these publications was found to be 72% (18 of 25) in those treated with isolated curettage, 13% (2 of 15) in those treated with curettage plus adjuvants, 15% (6 of 41) in those treated by resection and 10% (1 of 10) in those treated by amputation. We then retrospectively analysed 30 patients treated for GCT of the small bones of the hands and feet between 1987 and 2010 in five specialised centres. The primary treatment was curettage in six, curettage with adjuvants (phenol or liquid nitrogen with or without polymethylmethacrylate (PMMA)) in 18 and resection in six. We evaluated the rate of complications and recurrence as well as the factors that influenced their functional outcome. At a mean follow-up of 7.9 years (2 to 26) the rate of recurrence was 50% (n=3) in those patients treated with isolated curettage, 22% (n=4) in those treated with curettage plus adjuvants and 17% (n=1) in those treated with resection (p=0.404). The only complication was pain in one patient, which resolved after surgical removal of remnants of PMMA. We could not identify any individual factors associated with a higher rate of complications or recurrence. The mean post-operative Musculoskeletal Tumor Society scores were slightly higher after intra-lesional treatment including isolated curettage and curettage plus adjuvants (29 (20 to 30)) compared with resection (25 (15 to 30)) (p=0.091). Repeated curettage with adjuvants eventually resulted in the cure for all patients and is therefore a reasonable treatment for both primary and recurrent GCT of the small bones of the hands and feet.
引用
收藏
页码:838 / 845
页数:8
相关论文
共 50 条
  • [1] Long-term outcomes of ultrasonic scalpel treatment in giant cell tumor of long bones
    Sun, Sheng
    Zhang, Qiang
    Zhao, Chang-Song
    Cai, Juan
    ONCOLOGY LETTERS, 2014, 8 (01) : 145 - 150
  • [2] Long-term consequences from bladder perforation and/or violation in the presence of transitional cell carcinoma: Results of a small series and a review of the literature
    Mydlo, JH
    Weinstein, R
    Shah, S
    Solliday, M
    Macchia, RJ
    JOURNAL OF UROLOGY, 1999, 161 (04) : 1128 - 1132
  • [3] Long-term morbidity and mortality following bloodstream infection: A systematic literature review
    McNamara, John F.
    Righi, Elda
    Wright, Hugh
    Hartel, Gunter F.
    Harris, Patrick N. A.
    Paterson, David L.
    JOURNAL OF INFECTION, 2018, 77 (01) : 1 - 8
  • [4] Long-term outcomes in surgically intervened empyema patients: a systematic review
    Jolliffe, Jarrod
    Dunne, Ben
    Eckhaus, Jazmin
    Antippa, Phillip
    ANZ JOURNAL OF SURGERY, 2024, 94 (09) : 1491 - 1501
  • [5] Coronary artery bypass grafting in patients with concomitant solid tumours: early and long-term results
    Garatti, Andrea
    D'Ovidio, Mariangela
    Saitto, Guglielmo
    Daprati, Andrea
    Canziani, Alberto
    Mossuto, Eugenio
    D'Oria, Veronica
    Scarpanti, Matteo
    De Vincentiis, Carlo
    Parolari, Alessandro
    Menicanti, Lorenzo
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2020, 58 (03) : 528 - 536
  • [6] Long-term active problems in patients with cloacal exstrophy: A systematic review
    Musleh, Layla
    Privitera, Laura
    Paraboschi, Irene
    Polymeropoulos, Alexios
    Mushtaq, Imran
    Giuliani, Stefano
    JOURNAL OF PEDIATRIC SURGERY, 2022, 57 (03) : 339 - 347
  • [7] Long-term Functional Outcomes of Giant Cell Tumours around the Knee treated by Extended Curettage followed by Bone Grafting, Cementation, or a Combination
    Khan, Aq
    Raza, Q.
    Abbas, Mb
    Chowdhry, M.
    Khan, Mj
    MALAYSIAN ORTHOPAEDIC JOURNAL, 2024, 18 (03) : 42 - 50
  • [8] Long-term continuation of methotrexate therapy in giant cell arteritis patients in clinical practice
    Leon, L.
    Rodriguez-Rodriguez, L.
    Freites, D.
    Arietti, L.
    Morado, I.
    Vadillo, C.
    Lamas, J. R.
    Fernandez, B.
    Jover, J. A.
    Abasolo, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (01) : S165 - S170
  • [9] Pexidartinib Long-Term Hepatic Safety Profile in Patients with Tenosynovial Giant Cell Tumors
    Lewis, James H.
    Gelderblom, Hans
    van de Sande, Michiel
    Stacchiotti, Silvia
    Healey, John H.
    Tap, William D.
    Wagner, Andrew J.
    Pousa, Antonio Lopez
    Druta, Mihaela
    Lin, Chia-Chi
    Baba, Hideo A.
    Choi, Youngsook
    Wang, Qiang
    Shuster, Dale E.
    Bauer, Sebastian
    ONCOLOGIST, 2021, 26 (05) : E863 - E873
  • [10] Results of Long-Term Follow-Up of Patients With Completely Resected Non-Small Cell Lung Cancer
    Endo, Chiaki
    Sakurada, Akira
    Notsuda, Hirotsugu
    Noda, Masafumi
    Hoshikawa, Yasushi
    Okada, Yoshinori
    Kondo, Takashi
    ANNALS OF THORACIC SURGERY, 2012, 93 (04) : 1061 - 1069